FI942935A7 - Peptidien nukleiinihappoja ja niiden vaikutus geneettiseen materiaalii n - Google Patents
Peptidien nukleiinihappoja ja niiden vaikutus geneettiseen materiaalii n Download PDFInfo
- Publication number
- FI942935A7 FI942935A7 FI942935A FI942935A FI942935A7 FI 942935 A7 FI942935 A7 FI 942935A7 FI 942935 A FI942935 A FI 942935A FI 942935 A FI942935 A FI 942935A FI 942935 A7 FI942935 A7 FI 942935A7
- Authority
- FI
- Finland
- Prior art keywords
- peptides
- effect
- nucleic acids
- genetic material
- genetic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
- C07K14/003—Peptide-nucleic acids (PNAs)
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
- C08G69/02—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids
- C08G69/08—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids derived from amino-carboxylic acids
- C08G69/10—Alpha-amino-carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US80966191A | 1991-12-18 | 1991-12-18 | |
| PCT/US1992/010921 WO1993012129A1 (en) | 1991-12-18 | 1992-12-17 | Peptide nucleic acids and their effect on genetic material |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI942935A0 FI942935A0 (fi) | 1994-06-17 |
| FI942935L FI942935L (fi) | 1994-07-27 |
| FI942935A7 true FI942935A7 (fi) | 1994-07-27 |
Family
ID=25201908
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI942935A FI942935A7 (fi) | 1991-12-18 | 1992-12-17 | Peptidien nukleiinihappoja ja niiden vaikutus geneettiseen materiaalii n |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0618923A4 (https=) |
| JP (1) | JPH07502509A (https=) |
| AU (2) | AU3325493A (https=) |
| CA (1) | CA2125966A1 (https=) |
| FI (1) | FI942935A7 (https=) |
| MX (1) | MX9207334A (https=) |
| NO (1) | NO942327D0 (https=) |
| NZ (1) | NZ246473A (https=) |
| WO (1) | WO1993012129A1 (https=) |
| ZA (1) | ZA929764B (https=) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6441130B1 (en) | 1991-05-24 | 2002-08-27 | Isis Pharmaceuticals, Inc. | Linked peptide nucleic acids |
| DK51092D0 (da) * | 1991-05-24 | 1992-04-15 | Ole Buchardt | Oligonucleotid-analoge betegnet pna, monomere synthoner og fremgangsmaade til fremstilling deraf samt anvendelser deraf |
| US6451968B1 (en) * | 1991-05-24 | 2002-09-17 | Isis Pharmaceuticals, Inc. | Peptide nucleic acids |
| US5539082A (en) * | 1993-04-26 | 1996-07-23 | Nielsen; Peter E. | Peptide nucleic acids |
| US6713602B1 (en) | 1991-05-24 | 2004-03-30 | Ole Buchardt | Synthetic procedures for peptide nucleic acids |
| US7223833B1 (en) | 1991-05-24 | 2007-05-29 | Isis Pharmaceuticals, Inc. | Peptide nucleic acid conjugates |
| US6228982B1 (en) * | 1992-05-22 | 2001-05-08 | Benget Norden | Double-stranded peptide nucleic acids |
| US5700922A (en) * | 1991-12-24 | 1997-12-23 | Isis Pharmaceuticals, Inc. | PNA-DNA-PNA chimeric macromolecules |
| JP3131222B2 (ja) * | 1991-12-24 | 2001-01-31 | アイシス・ファーマシューティカルス・インコーポレーテッド | ギャップを有する2′修飾オリゴヌクレオチド |
| US6277603B1 (en) | 1991-12-24 | 2001-08-21 | Isis Pharmaceuticals, Inc. | PNA-DNA-PNA chimeric macromolecules |
| US6350853B1 (en) | 1993-04-26 | 2002-02-26 | Peter E. Nielsen | Conjugated peptide nucleic acids having enhanced cellular uptake |
| US5527675A (en) * | 1993-08-20 | 1996-06-18 | Millipore Corporation | Method for degradation and sequencing of polymers which sequentially eliminate terminal residues |
| DE4331012A1 (de) * | 1993-09-13 | 1995-03-16 | Bayer Ag | Nukleinsäuren-bindende Oligomere mit N-Verzweigung für Therapie und Diagnostik |
| US6133444A (en) * | 1993-12-22 | 2000-10-17 | Perseptive Biosystems, Inc. | Synthons for the synthesis and deprotection of peptide nucleic acids under mild conditions |
| DE69430704T2 (de) * | 1993-12-22 | 2003-01-30 | Perseptive Biosystems, Inc. | Guaninsynthone für die synthese von nucleinsäuren und verfahren zu deren herstellung |
| DK145493D0 (da) * | 1993-12-23 | 1993-12-23 | Dako As | Antistof |
| US5539083A (en) * | 1994-02-23 | 1996-07-23 | Isis Pharmaceuticals, Inc. | Peptide nucleic acid combinatorial libraries and improved methods of synthesis |
| DE4408533A1 (de) * | 1994-03-14 | 1995-09-28 | Hoechst Ag | PNA-Synthese unter Verwendung einer basenlabilen Amino-Schutzgruppe |
| DE4408534A1 (de) * | 1994-03-14 | 1995-09-28 | Hoechst Ag | Substituierte N-Ethyl-Glycinderivate zur Herstellung von PNA und PNA-/DNA-Hybriden |
| DE4408531A1 (de) * | 1994-03-14 | 1995-09-28 | Hoechst Ag | PNA-Synthese unter Verwendung einer gegen schwache Säuren labilen Amino-Schutzgruppe |
| DE4427980A1 (de) * | 1994-08-08 | 1996-02-15 | Bayer Ag | Nukleinsäuren-bindende Oligomere für Therapie und Diagnostik |
| AU3999495A (en) * | 1994-10-06 | 1996-05-02 | Buchardt, Dorte | Peptide nucleic acid conjugates |
| WO1996020212A2 (en) * | 1994-12-28 | 1996-07-04 | Buchardt, Dorte | Peptide nucleic acid incorporating a chiral backbone |
| US6465650B1 (en) | 1995-03-13 | 2002-10-15 | Aventis Pharma Deutschland Gmbh | Substituted N-ethylglycine derivatives for preparing PNA and PNA/DNA hybrids |
| DE69632324T2 (de) * | 1995-06-07 | 2005-06-16 | PerSeptive Biosystems, Inc., Framingham | Pna-dna-chimäre und pna-synthone zu deren herstellung |
| WO1997014793A1 (en) * | 1995-10-20 | 1997-04-24 | Trustees Of Boston University | Nucleic acid clamps |
| DE19653646A1 (de) * | 1996-12-20 | 1998-06-25 | Hoechst Ag | Substituierte Purinderivate, Verfahren zu deren Herstellung, sie enthaltende Mittel und deren Verwendung |
| US6617422B1 (en) | 1997-05-23 | 2003-09-09 | Peter Nielsen | Peptide nucleic acid monomers and oligomers |
| WO1998058256A1 (en) * | 1997-06-16 | 1998-12-23 | The University Of North Carolina At Chapel Hill | PEPTIDO OLIGONUCLEOTIDES (PONs) AND THEIR COMBINATORIAL LIBRARIES |
| WO2000002864A1 (en) * | 1998-07-10 | 2000-01-20 | Martens Juergen | Precusors for pna-monomers |
| US6921812B1 (en) | 2001-07-03 | 2005-07-26 | Isis Pharmaceuticals, Inc. | Methods of modulating pharmacokinetics of oligonucleotides |
| LT1576138T (lt) | 2002-11-15 | 2017-06-26 | Idenix Pharmaceuticals Llc | 2`-šakoti nukleozidai derinyje su interferonu ir flaviviridae mutacija |
| WO2007073149A1 (en) | 2005-12-22 | 2007-06-28 | Keygene N.V. | Alternative nucleotides for improved targeted nucleotide exchange |
| EP2678026B1 (en) | 2011-02-21 | 2016-05-18 | The University of Zurich | Ankyrin g for use in the treatment of neurodegenerative disorders |
| US9347095B2 (en) | 2013-03-15 | 2016-05-24 | Bio-Rad Laboratories, Inc. | Digital assays for mutation detection |
| CN110740994A (zh) * | 2017-03-23 | 2020-01-31 | 特鲁科德基因修复公司 | 具有受正交保护的酯部分的肽核酸(pna)单体 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1986005519A1 (en) * | 1985-03-15 | 1986-09-25 | James Summerton | Polynucleotide assay reagent and method |
| DK51092D0 (da) * | 1991-05-24 | 1992-04-15 | Ole Buchardt | Oligonucleotid-analoge betegnet pna, monomere synthoner og fremgangsmaade til fremstilling deraf samt anvendelser deraf |
-
1992
- 1992-12-16 MX MX9207334A patent/MX9207334A/es unknown
- 1992-12-17 JP JP5511176A patent/JPH07502509A/ja active Pending
- 1992-12-17 ZA ZA929764A patent/ZA929764B/xx unknown
- 1992-12-17 NZ NZ246473A patent/NZ246473A/en unknown
- 1992-12-17 AU AU33254/93A patent/AU3325493A/en not_active Abandoned
- 1992-12-17 EP EP93901215A patent/EP0618923A4/en not_active Withdrawn
- 1992-12-17 FI FI942935A patent/FI942935A7/fi unknown
- 1992-12-17 CA CA002125966A patent/CA2125966A1/en not_active Abandoned
- 1992-12-17 WO PCT/US1992/010921 patent/WO1993012129A1/en not_active Ceased
-
1994
- 1994-06-17 NO NO942327A patent/NO942327D0/no not_active Application Discontinuation
-
1996
- 1996-10-21 AU AU70325/96A patent/AU7032596A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JPH07502509A (ja) | 1995-03-16 |
| WO1993012129A1 (en) | 1993-06-24 |
| AU3325493A (en) | 1993-07-19 |
| EP0618923A1 (en) | 1994-10-12 |
| NZ246473A (en) | 1996-05-28 |
| CA2125966A1 (en) | 1993-06-24 |
| MX9207334A (es) | 1993-08-01 |
| FI942935L (fi) | 1994-07-27 |
| ZA929764B (en) | 1993-10-13 |
| EP0618923A4 (en) | 1998-05-20 |
| NO942327D0 (no) | 1994-06-17 |
| NO942327L (https=) | 1994-08-17 |
| FI942935A0 (fi) | 1994-06-17 |
| AU7032596A (en) | 1997-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI942935A7 (fi) | Peptidien nukleiinihappoja ja niiden vaikutus geneettiseen materiaalii n | |
| FI922609A7 (fi) | Proteiinit ja nukleiinihapot | |
| NO943344L (no) | MN-gen og -protein | |
| FI935485A7 (fi) | PEG-hydratsoni- ja PEG-oksiimisidoksen muodostavat reagenssit ja niiden proteiinijohdannaiset | |
| ATE328902T1 (de) | Selektive acylierung von epsilon-aminogruppen in insulin | |
| FI955552L (fi) | Adenoviraalisia eläinperäisiä vektoreita ja niiden käyttö geeniterapiassa | |
| FI954978L (fi) | Modifioidut proteiini- ja peptidilääkeaineet | |
| DE69526801D1 (de) | Aerosolformulierungen mit peptiden und proteinen | |
| FI954329L (fi) | Farmaseuttisina aineina käytettäviä nukleiinihappoja | |
| FI940845A7 (fi) | Vettä absorboiva koostumus ja materiaali | |
| FI924747A7 (fi) | PEG-imidaatteja ja niiden proteiinijohdannaisia | |
| EP0948651A4 (en) | RECOMBINANT N-SMASES AND CODING NUCLEIC ACIDS | |
| BR8905738A (pt) | Material de formulario comercial e sobrescritos | |
| FI905825A7 (fi) | Amfifiiliset peptidit ja niiden käyttö | |
| FR2625974B1 (fr) | Bouteille en materiau thermoplastique | |
| NO905561D0 (no) | Proteiner og nukleinsyrer. | |
| GB9023149D0 (en) | Proteins and nucleic acids | |
| DE69230825D1 (de) | Genexpression in bazillen | |
| FI971085A7 (fi) | Uusia PKA:ta sitovia proteiineja ja näiden käyttömuotoja | |
| DE59407311D1 (de) | Leukoindigo-präparationen in granulatform | |
| ZA921892B (en) | Proteins and nucleic acids | |
| DE69326230D1 (de) | Insertionselemente und amplifizierbare nukleinsäuren | |
| FI971863A0 (fi) | Fluoributenyyliesterit ja niiden käyttö tuhoeläinten torjumiseksi | |
| DE69406541D1 (de) | Farbkontrolle und stabilitätsverbesserungen in acetaminophen | |
| GB9116325D0 (en) | Proteins and nucleic acids |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GB | Transfer or assigment of application |
Owner name: ISIS PHARMACEUTICALS, INC. |